Where does Ulthera, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ulthera, Inc. ranks #6,966 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ulthera, Inc. hold?

Ulthera, Inc. holds 48 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is Ulthera, Inc.'s Innovation Score?

Ulthera, Inc. has an Innovation Score of 39.2 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Ulthera, Inc. focus on?

Ulthera, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 36 patents, ranking #527 of 7,127 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Ulthera, Inc.'s patent grant rate increasing or decreasing?

Ulthera, Inc.'s recent grant velocity is +14% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Ulthera, Inc.'s patents?

Ulthera, Inc.'s patents average 15.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Ulthera, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Ulthera, Inc.

USPTO PatentsView assignee record - 48 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ulthera ranks #6,966 of 49,997 tracked US assignees by granted-patent volume, with 48 patents across 11 technology areas.

#6,966
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.2/100): 15.3
avg claims per patent: +14%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6966 · US Corporation #6,966 · 48 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 48 grants
UPPER-Q #6,966/49,997
PHOTO-FINISH Toyota Motor
CPC-FOCUS A61B · 11 areas
INNOV-THIN 39.2/100
CLAIMS-RICH 15.3 claims/avg
TYPE-USCORP US Corporation
VEL-UP +14% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Toyota Motor Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ulthera’s 39.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.4 pts (34%) Velocity 4.8 pts (12%) Breadth 11.7 pts (30%) Claim depth 9.2 pts (24%)

Qualcomm Incorporated · highest

85
Allergan Pharmaceuti… · near

39
API · near

39
fischerwerke & KG · near

39
Ulthera · this assignee

39
Vishay Dale · near

39
3D Lighting… · lowest

7

What this shows Ulthera's Innovation Score is 39.2/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ulthera?

Each dot is one of Ulthera’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ulthera’s own 15.3 claims/patent is ABOVE the 14.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ulthera vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ulthera's grants concentrate

Ulthera, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 75% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (9 grants) versus a trough of 1 in 2017. By volume, Ulthera sits between Toyota Motor Corporation and Victoria Link Ltd..

Ulthera's three-year grant acceleration

Ulthera, Inc. shows 13 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Toyota Motor

48
Trico Products

48
Tusker Medical

48
Universite D'ange…

48
United Semiconduc…

48
Vapotherm

48
Verinata Health

48
Victoria Link

48
Ulthera ◀

48

What this shows Ulthera holds 48 patents at rank #6,966, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ulthera

By rank, the assignees closest to #6,966 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Ulthera's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ulthera, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Ulthera ranks #527 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Vishay Dale Electronics, LLC 39 API Corporation 39 fischerwerke GmbH & Co. KG 39 Allergan Pharmaceuticals International Limited 39

Ulthera's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Ulthera, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	16.7%
2016	7	14.6%
2017	1	2.1%
2019	6	12.5%
2020	9	18.8%
2021	3	6.3%
2022	7	14.6%
2023	2	4.2%
2024	4	8.3%
2025partial year	1	2.1%

Which technologies does Ulthera, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 36

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 33

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 13

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 11

G10K - Sound-producing DEVICES; Methods OR Devices FOR Protecting Against, OR FOR Damping, Noise OR Other Acoustic Waves IN GENERAL; Acoustics NOT Otherwise Provided FOR 6

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 6

A45D - Hairdressing OR Shaving Equipment ; Equipment FOR Cosmetics OR Cosmetic Treatments, e.g. FOR Manicuring OR Pedicuring 4

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 2

B06B - Methods OR Apparatus FOR Generating OR Transmitting Mechanical Vibrations OF Infrasonic, Sonic, OR Ultrasonic Frequency, ; e.g.; FOR Performing Mechanical Work IN General 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ulthera, Inc.'s patent record in context - here's where to go next.

Ulthera, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 75% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #6,966 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ulthera, Inc. against Toyota Motor Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.